Art

J-GLOBAL ID：201502218516900828   Reference number：15A1289190

Pemetrexed-Induced Rash May Be Prevented by Supplementary Corticosteroids

ペメトレキセド誘発性発疹は補充性コルチコステロイドにより予防できるかもしれない

Author (16)： SAKURADA Takumi (Dep. of Pharmacy, Tokushima Univ. Hospital) ,  KAKIUCHI Soji (Dep. of Medical Oncology, Inst. of Biomedical Sciences, The Univ. of Tokushima Graduate School) ,  KAKIUCHI Soji (Dep. of Respiratory Medicine and Rheumatology, Inst. of Biomedical Sciences, The Univ. of Tokushima Graduate School) ,  TAJIMA Soichiro (Dep. of Pharmacy, Kyushu Univ. Hospital) ,  HORINOUCHI Yuya (Dep. of Pharmacy, Tokushima Univ. Hospital) ,  KONAKA Ken (Dep. of Pharmacy, Tokushima Univ. Hospital) ,  OKADA Naoto (Dep. of Pharmacy, Tokushima Univ. Hospital) ,  NISHISAKO Hirotaka (Dep. of Pharmacy, Tokushima Univ. Hospital) ,  NAKAMURA Toshimi (Dep. of Pharmacy, Tokushima Univ. Hospital) ,  TERAOKA Kazuhiko (Dep. of Pharmacy, Tokushima Univ. Hospital) ,  KAWAZOE Kazuyoshi (Dep. of Pharmacy, Tokushima Univ. Hospital) ,  KAWAZOE Kazuyoshi (Dep. of Clinical Pharmacy, Inst. of Biomedical Sciences, The Univ. of Tokushima Graduate School) ,  YANAGAWA Hiroaki (Clinical Trial Center for Developmental Therapeutics, Tokushima Univ. Hospital) ,  NISHIOKA Yasuhiko (Dep. of Respiratory Medicine and Rheumatology, Inst. of Biomedical Sciences, The Univ. of Tokushima Graduate School) ,  ISHIZAWA Keisuke (Dep. of Pharmacy, Tokushima Univ. Hospital) ,  ISHIZAWA Keisuke (Dep. of Clinical Pharmacy, Inst. of Biomedical Sciences, The Univ. of Tokushima Graduate School)
Material： Biological and Pharmaceutical Bulletin  (Biological & Pharmaceutical Bulletin)
Volume： 38  Issue： 11  Page： 1752-1756 (J-STAGE)  Publication year： 2015 
JST Material Number： S0989A  ISSN： 0918-6158  CODEN： BPBLEO  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A1289190&from=J-GLOBAL&jstjournalNo=S0989A") }}

JST classification (1)： Clinical dermatology in general  (GF01030J)

Substance index (2)： Dexamethasone ,  Pemetrexed

Reference (30)：

• 1) Shih C, Habeck LL, Mendelsohn LG, Chen VJ, Schultz RM. Multiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidine-based antifolate LY231514 (MTA). Adv. Enzyme Regul., 38, 135-152 (1998).
• 2) Taylor EC, Patel HH. Synthesis of pyrazolo[3,4-d]pyrimidine analogues of the potent antitumor agent N-4-[2-(2-amino-4(3H)-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl-L-glutamic acid (LY231514). Tetrahedron, 48, 8089-8100 (1992).
• 3) Rusthoven JJ, Eisenhauer E, Butts C, Gregg R, Dancey J, Fisher B, Iglesias J. Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials Group. J. Clin. Oncol., 17, 1194 (1999).
• 4) Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J. Clin. Oncol., 21, 2636-2644 (2003).
• 5) Hanauske AR, Chen V, Paoletti P, Niyikiza C. Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors. Oncologist, 6, 363-373 (2001).

Terms in the title (5)： ペメトレキセド ,  発疹 ,  補充 ,  コルチコステロイド ,  予防